经导管主动脉瓣植入术后30天再入院率的医院间差异
结果显示医院间30天RSRR存在显著差异(中位OR 1.22,95%CI 1.16-1.32,p<0.01),患者、医院和经济因素分别解释9.6%、1.9%和3.8%的变异。
要点
- TAVI术后30天风险标准化再入院率存在显著医院间差异。
- 患者因素解释9.6%的再入院率变异,医院因素仅1.9%。
- 需采取措施减少TAVI术后再入院率的医院间差异。
核心结论
- TAVI术后30天风险标准化再入院率存在显著的医院间差异。
- 需进一步采取措施缩小再入院率的变异。
研究设计与样本
- 回顾性队列研究,使用2017年美国全国再入院数据库。
主要发现
- 30天粗再入院率范围为2.0%-33.3%,30天风险标准化再入院率范围为9.4%-15.3%。
- 30天风险标准化再入院率中位数为11.8%,医院间变异显著(中位OR 1.22,95%CI 1.16-1.32,p<0.01)。
- 因主要心脏和非心脏疾病导致的再入院中,医院间变异相似。
- 患者、医院和经济因素分别解释9.6%、1.9%和3.8%的再入院率变异。
临床怎么用
- 临床应关注TAVI术后30天再入院率的医院间差异,针对患者因素优化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Thirty-day readmission rate is one of the hospital quality metrics. Outcomes of transcatheter aortic valve implantation (TAVI) have improved significantly, but it remains unclear whether hospital-level variance in 30-day readmission rate exists in the contemporary TAVI era. METHODS: From the 2017 US Nationwide Readmission Database, endovascular TAVI were identified. The unadjusted 30-day readmission rate and 30-day risk-standardised readmission rate (RSRR) were calculated and we then conducted model testing to determine the relative contribution of hospital characteristics, patient-level covariates and economic status to the variation in readmission rates observed between the hospitals. RESULTS: A total of 44 899 TAVI from 338 hospitals were identified. The range of unadjusted 30-day readmission rate and 30-day RSRR was 2.0%-33.3% and 9.4%-15.3%, respectively. Median 30-day RSRR was 11.8% and there was a significant hospital-level variation (median OR 1.22, 95% CI 1.16 to 1.32, p<0.01) and this was similar in both readmissions caused due to major cardiac and non-cardiac conditions. Patient, hospital and economic factors accounted for 9.6%, 1.9% and 3.8% of the variability in hospital readmission rate, respectively. CONCLUSIONS: There was significant hospital-level variation in 30-day RSRR following TAVI. Further measures are required to mitigate this variance in the readmission rate.
引用
- Ando T, Ashraf S, Kuno T, et al. Hospital variation of 30-day readmission rate following transcatheter aortic valve implantation. Heart. 2021. PMID: 33627399. doi:10.1136/heartjnl-2020-318583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。